Article
Nonglycemic Effects of SGLT2 Inhibitors: Focus on Inflammation and Macrophages
2024-11-08
Abstract excerpt
A growing body of evidences indicates that nonglycemic effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors play an important role in the protective effects of these drugs in diabetes, chronic kidney disease, and heart failure. In recent years, the anti-inflammatory potential of SGLT2 inhibitors has been actively studied. This review summarizes results of clinical and experimental studies on the anti-infla...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 144ec275-0088-53a6-9516-d5f6c936e20b
- DOI
- 10.20944/preprints202411.0540.v1
